ABSTRACT
The pathogenesis of rheumatoid arthritis (RA) is incompletely understood. Human endogenous retroviruses (HERVs) and their superantigenic envelope protein (env) have been implicated in the pathogenesis of RA. In the present investigation, the arthritogenic potential of the superantigen staphylococcal enterotoxin A (SEA) has been investigated. In the present investigation, the bacterial superantigen staphylococcal enterotoxin A (SEA) was injected into the right knee joint of 15 Lewis rats. Further nine animals received saline. Animals were sacrificed one, five and 10 days after the injection, respectively. The antigens CD3, CD4, CD8, MHC class I, MHC class II, Pax5 and CD138 were investigated by immunohistochemistry on cryo-sections. After intra-articular SEA injection, the inflammation was initially dominated by CD8+ T cells. In the course of the investigation, the numbers of CD4+, Pax5+, CD138+ and MHC class II+ cells increased. CD3 was expressed in low numbers as compared to CD8. After saline injection, no similar inflammatory response has been detected. The arthritis induced by the superantigen SEA may be a novel model for inflammatory joint diseases, that is rheumatoid arthritis or juvenile idiopathic arthritis.
Subject(s)
Arthritis, Experimental/immunology , Arthritis, Experimental/pathology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Enterotoxins/immunology , Superantigens/immunology , Animals , Arthritis, Rheumatoid/pathology , B-Lymphocytes/immunology , CD3 Complex/metabolism , CD4 Antigens/metabolism , CD8 Antigens/metabolism , Disease Models, Animal , Histocompatibility Antigens Class I/metabolism , Histocompatibility Antigens Class II/metabolism , Male , PAX5 Transcription Factor/metabolism , Rats , Rats, Inbred Lew , Syndecan-1/metabolismSubject(s)
Endogenous Retroviruses/immunology , Multiple Sclerosis, Chronic Progressive/immunology , Superantigens/immunology , Apoptosis/immunology , Axons/immunology , B-Lymphocytes/immunology , Brain/immunology , Endogenous Retroviruses/genetics , Epstein-Barr Virus Infections/immunology , Humans , Nerve Degeneration/immunology , Oligoclonal Bands/blood , Oligodendroglia/immunology , T-Lymphocytes/immunology , Trans-ActivatorsABSTRACT
The antifolate methotrexate (MTX) is an important chemotherapeutic agent for treatment of osteosarcoma. This drug is converted intracellularly into polyglutamate derivates by the enzyme folylpolyglutamate synthase (FPGS). MTX polyglutamates show an enhanced and prolonged cytotoxicity in comparison to the monoglutamate. In the present study, we proved the hypothesis that transfer of the human fpgs gene into osteosarcoma cells may augment their MTX sensitivity. For this purpose, we employed the human osteocalcin (OC) promoter, which had shown marked osteosarcoma specificity in promoter studies using different luciferase assays in osteosarcoma and non-osteosarcoma cell lines. A recombinant lentiviral vector was generated with the OC promoter driving the expression of fpgs and the gene for enhanced green fluorescent protein (egfp), which was linked to fpgs by an internal ribosomal entry site (IRES). As the vector backbone contained only a self-inactivating viral LTR promoter, any interference of the OC promoter by unspecific promoter elements was excluded. We tested the expression of FPGS and enhanced green fluorescent protein (EGFP) after lentiviral transduction in various osteosarcoma cell lines (human MG-63 cells and TM 791 cells; rat osteosarcoma (ROS) 17/2.8 cells) and non-osteogenic tumor cell lines (293T human embryonic kidney cells, HeLa human cervix carcinoma cells). EGFP expression and MTX sensitivity were assessed in comparison with non-transduced controls. Whereas the OC promoter failed to enhance MTX sensitivity via FPGS expression in non-osteogenic tumor cell lines, the OC promoter mediated a markedly increased MTX cytotoxicity in all osteosarcoma cell lines after lentiviral transduction. The present chemotherapy-enhancing gene therapy system may have great potential to overcome in future MTX resistance in human osteosarcomas.
Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Bone Neoplasms/genetics , Gene Expression/drug effects , Methotrexate/pharmacology , Osteosarcoma/genetics , Peptide Synthases/genetics , Cell Line, Tumor , Cloning, Molecular , Gene Order , Genes, Reporter , Genetic Vectors/genetics , Humans , Lentivirus/genetics , Organ Specificity/genetics , Osteocalcin/genetics , Osteocalcin/metabolism , Promoter Regions, Genetic , Transduction, Genetic , Transfection , Tumor Cells, CulturedABSTRACT
In the present investigation, T-cell subsets of the previously described superantigen-induced encephalitis [9] have been investigated in 16 Lewis rats in comparison with four controls. Three days after intracerebral injection of Staphylococcal Enterotoxin A (SEA) or saline, 1.5 x 10(7) ConA-activated splenocytes were loaded i.v. animals were sacrificed after 0.5, 3 or 5 days, followed by immunohistochemical investigation of CD3, CD4 and CD8. Pronounced perivascular cuffing was identified 0.5 days after splenocyte injection and declined thereafter. The majority of the perivascular round cells consisted of CD8+ T-cells (65%) and CD4+ T-cells (10%). Less than 20% of the perivascular round cells were CD3+. The reduced expression of CD3 relative to e.g. CD8 is presumably due to the previous superantigenic stimulus. The presented data may be of relevance for the pathogenesis of infectious or autoimmune encephalitis, e.g. in multiple sclerosis.
Subject(s)
Antigens, CD/biosynthesis , Encephalitis/immunology , Multiple Sclerosis/immunology , T-Lymphocyte Subsets/metabolism , Adoptive Transfer , Animals , Antigens, CD/genetics , Disease Models, Animal , Encephalitis/chemically induced , Enterotoxins/administration & dosage , Immunohistochemistry , Multiple Sclerosis/therapy , Rats , Rats, Inbred Lew , Superantigens/administration & dosage , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/pathologyABSTRACT
Inducible co-stimulator (ICOS) interaction with its ligand (ICOSL) is involved in several T cell effector functions. While blockade of ICOS:ICOSL interaction in chronic graft versus host disease (GVHD) seems beneficial, results for acute GVHD remain controversial. To further elucidate its role in acute GVHD, C57BL/6 mice were reconstituted with allogeneic spleen cells in the absence or presence of ICOSL-blocking mAb. Mice reconstituted with allogeneic spleen cells experienced severe GVHD and died untreated within 6-9 days after transplantation. Mice treated with an anti-ICOSL mAb starting from day 3 after transplantation gained weight again and survived for at least additional 12 days, although the treatment was already stopped at day 11 after transplantation. In contrast, the anti-ICOSL treatment starting from day 0 did not prevent GVHD. The difference between therapeutic (day 3) and prophylactic (day 0) anti-ICOSL treatment was independent of CD25+CD4+ regulatory T cells since their depletion did not abrogate the therapeutic effect of ICOSL blockade. Microarray analysis revealed IFN-gamma and chemokine up-regulation in spleen cells of prophylactically treated mice, emphasizing kinetic dependence of acute GVHD modulation via blockade of ICOS:ICOSL interaction.
Subject(s)
Antibodies, Monoclonal/pharmacology , Antigens, Differentiation, T-Lymphocyte/drug effects , Graft vs Host Disease/immunology , Proteins/antagonists & inhibitors , Animals , Bone Marrow Transplantation , Chemokines/metabolism , Drug Administration Schedule , Female , Inducible T-Cell Co-Stimulator Ligand , Inducible T-Cell Co-Stimulator Protein , Interferon-gamma/metabolism , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Oligonucleotide Array Sequence Analysis , Spleen/immunology , Spleen/transplantation , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Up-RegulationABSTRACT
Human antigen presenting cells commonly express CD4 but the significance of this phenomenon has not been clarified. We analyzed a panel of Epstein-Barr virus-immortalized B cells (so called lymphoblastoid cell lines, LCL) by using flow cytometry, DNA-microarray analysis, and reverse transcriptase-polymerase chain reaction (RT-PCR). The number of CD4(+) cells varied from cell line to cell line but expression of CD4 was detected by flow cytometry and RT-PCR in all investigated cell lines. To characterize CD4 expressing LCL in more detail, we separated CD4(+) and CD4(-) cells from single cell lines by using immunomagnetic beads. When we cultured sorted CD4(+) and CD4(-) cells, we observed that CD4 expression was stable for several passages. However, the number of CD4(+) cells decreased with time in culture. We never observed that CD4(-) cell lines returned back to a CD4(+) phenotype. DNA-microarray analysis of isolated CD4(+) and CD4(-) cells indicated that the overall gene expression profile of both cell populations was highly similar. In addition, CD4(+) and CD4(-) cells showed the same allostimulatory capacity. CD4(+) LCL showed a slightly increased interleukin-16 induced chemotaxis. Differences in the gene expression profile of CD4(+) and CD4(-) cell lines suggested that loss of CD4 expression occurred during a differentiation step involving achaete-scute complex homolog-like 1.
Subject(s)
B-Lymphocytes/metabolism , Basic Helix-Loop-Helix Transcription Factors/metabolism , CD4 Antigens/metabolism , Herpesvirus 4, Human , Antigens, CD/metabolism , B-Lymphocytes/virology , Cell Line, Tumor , Chemotaxis/drug effects , Chemotaxis/physiology , Gene Expression Profiling , Humans , Interleukin-16/pharmacology , Oligonucleotide Array Sequence AnalysisABSTRACT
Superantigens were suggested to play a role in the pathogenesis of different autoimmune diseases including multiple sclerosis (MS). Previously, it was demonstrated that local expression of the superantigen, staphylococcal enterotoxin A (SEA) in the brain of rats may lead to encephalitis which was amplified by using intravenous injection of concanavalin A (ConA)-activated splenocytes. In the present investigation, gene expression was studied in the rat brain 8 days after an injection of 50 mul of 1 mg/ml SEA or saline and 5 days after an intravenous injection of 1 x 10(7) ConA-activated spleen cells. Of 8800 genes investigated (Affymetrix, rat genome U34A), the expression of 106 genes was significantly and at least threefold increased with SEA, while the expression of 29 genes was decreased at least threefold. Increased gene expression was compatible with an intracerebral inflammatory response mediated by antigen-presenting cells and CD8+ T lymphocytes. Elevated chemokines comprised RANTES (CCL5), osteopontin, MCP-1 (CCL2) and CXCL10. Further, genes with increased expression were assigned to the extracellular matrix, microglia/macrophage cell elements, astrocytes (GFAP) and phagocytosis. There was considerable conformity between previously reported gene expression profiles for experimental autoimmune encephalomyelitis (EAE) or MS and the present findings. Our data are in line with the concept that T-cell superantigen locally expressed in the central nervous system induces an inflammatory response. Therefore, the study of gene expression profiles does not seem to allow clear conclusions with respect to the aetiology of central nervous system autoimmune diseases.
Subject(s)
Encephalitis/genetics , Enterotoxins/immunology , Gene Expression Regulation , Superantigens/genetics , Animals , Antigen-Presenting Cells/immunology , Astrocytes/metabolism , Brain/immunology , Brain/pathology , CD8-Positive T-Lymphocytes/immunology , Chemokines/biosynthesis , Chemokines/genetics , Encephalitis/chemically induced , Encephalitis/immunology , Encephalitis/pathology , Enterotoxins/adverse effects , Inflammation/pathology , Macrophages/immunology , Male , Mice , Microglia/immunology , Rats , Rats, Inbred LewABSTRACT
UNLABELLED: We characterized the functional properties of mesenchymal stem cells from various human tissues for their potential to differentiate into hepatocyte-like cells in vitro. METHODS: Mesenchymal stem cells were isolated from human bone marrow (hBM-MSC) and peritoneal and subcutaneous adipose tissues (hpAT-MSC and hsAT-MSC) based on their capacity to adhere to plastic culture surfaces. Cells were analyzed by reverse transcriptase polymerase chain reaction and for urea as well as glycogen synthesis. Their potential for multiple differentiation pathways was investigated by incubation in culture media triggering osteogenic, adipogenic, or hepatogenic features. Global gene expression patterns were analyzed in hepatocyte differentiated hBM-MSC compared with undifferentiated MSC and adult and fetal human liver. RESULTS: Applying osteogenic or adipogenic differentiation conditions, the cells from each tissue under investigation differentiated appropriately. Treatment of the cells with hepatogenic medium induced mRNA transcripts typical for hepatocytes, as well as the onset of urea synthesis and glycogen storage. Analysis of global gene expression patterns revealed that hepatocytes differentiated from hBM-MSC were clearly distinct from undifferentiated MSC. These cells had acquired features of adult as well as fetal human hepatocytes. CONCLUSION: In vitro, MSC from human bone marrow and adipose tissue differentiated to hepatocyte-like cells closely related to adult elements on the molecular and functional levels.
Subject(s)
Cell Differentiation/physiology , Hepatocytes/cytology , Hepatocytes/transplantation , Stem Cells/cytology , Adipose Tissue/cytology , Bone Marrow Cells/cytology , Hepatocytes/physiology , Humans , Liver Diseases/surgery , Oligonucleotide Array Sequence Analysis , Osteoblasts/cytology , RNA, Messenger/genetics , Stem Cells/physiology , Transcription, GeneticSubject(s)
Chromosome Inversion , DNA-Binding Proteins/genetics , Leukemia-Lymphoma, Adult T-Cell/genetics , Myeloid-Lymphoid Leukemia Protein/genetics , Nuclear Proteins/genetics , Transcription Factors/genetics , Adolescent , Chromosomes, Human, Pair 11 , Disease-Free Survival , Hematopoietic Stem Cell Transplantation , Humans , Male , Neoplasms, Second Primary/genetics , Oncogene Proteins, Fusion , Trans-ActivatorsABSTRACT
Invasive aspergillosis is an increasing problem in immuno-incompetent patients after prolonged steroid therapy, cancer radio-chemotherapy, and bone marrow or solid organ transplantation. Cerebral aspergillosis is a well-described complication of the invasive aspergillosis but only in rare cases, the brain is the sole site of infection. Despite increasing availability of antifungal drugs, the prognosis of cerebral aspergillosis is poor. We report on an 11-year-old boy with medulloblastoma in the area of the fourth ventricle. Following tumor surgery and radio-chemotherapy, several abscess-like structures occurred in the operating field. After incomplete abscess, resection histology and culture confirmed a localized Aspergillus fumigatus infection. The initial treatment of the Aspergillus fumigatus infection with conventional amphotericin B failed, and treatment with the triazole voriconazole was started. Intravenous treatment with voriconazole resulted in a reduction of the Aspergillus fumigatus abscess. After switching to oral ambulatory therapy, the Aspergillus fumigatus abscess increased in size. To improve treatment, voriconazole dosage was adapted to reach drug concentrations in cerebrospinal fluid (CSF) above the minimal fungicidal concentration and plasma specimens. During the concentration-controlled voriconazole therapy for a period of 18 months, a complete response was achieved.
Subject(s)
Antifungal Agents/therapeutic use , Aspergillus fumigatus , Brain Abscess/drug therapy , Cerebral Ventricle Neoplasms/complications , Medulloblastoma/complications , Neuroaspergillosis/drug therapy , Pyrimidines/therapeutic use , Surgical Wound Infection/drug therapy , Triazoles/therapeutic use , Administration, Oral , Antifungal Agents/administration & dosage , Antifungal Agents/cerebrospinal fluid , Antifungal Agents/pharmacology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Aspergillus fumigatus/drug effects , Brain Abscess/diagnosis , Brain Abscess/etiology , Brain Abscess/microbiology , Carboplatin/administration & dosage , Cerebral Ventricle Neoplasms/drug therapy , Cerebral Ventricle Neoplasms/radiotherapy , Cerebral Ventricle Neoplasms/surgery , Child , Combined Modality Therapy , Cranial Irradiation , Craniotomy , Cyclophosphamide/administration & dosage , Diagnostic Errors , Etoposide/administration & dosage , Humans , Immunocompromised Host , Infusions, Intravenous , Lomustine/administration & dosage , Male , Medulloblastoma/drug therapy , Medulloblastoma/radiotherapy , Medulloblastoma/surgery , Methotrexate/administration & dosage , Neoplasm Recurrence, Local/diagnosis , Neuroaspergillosis/complications , Neuroaspergillosis/diagnosis , Pyrimidines/administration & dosage , Pyrimidines/cerebrospinal fluid , Pyrimidines/pharmacology , Surgical Wound Infection/etiology , Triazoles/administration & dosage , Triazoles/cerebrospinal fluid , Triazoles/pharmacology , Vincristine/administration & dosage , VoriconazoleABSTRACT
DNA-microarrays allow the analysis of almost the complete gene expression program of tumor samples and normal control samples in a single experiment. This allows the processing of a large number of samples in a reasonable short time. Tumor specific gene expression profiles can be used for molecular tumor classification and as a new diagnostic tool. In addition, the identification of tumor specific genes can help to understand the biology of tumor cells and identified genes can be used for the development of new therapeutic strategies. However, the huge amount of data generated by DNA-microarrays creates new challenges for data analysis. In addition, accuracy and reproducibility of the available techniques require complementary methods for verification of DNA-microarray data.
Subject(s)
Gene Expression Profiling , Neoplasm Proteins/genetics , Neoplasms/genetics , Oligonucleotide Array Sequence Analysis , Child , Gene Expression Regulation, Neoplastic/physiology , Genetic Therapy , Humans , Immunotherapy , Neoplasms/diagnosis , Neoplasms/therapy , Predictive Value of TestsABSTRACT
Epstein-Barr virus (EBV) immortalized cells and Burkitt lymphoma cells have a completely different growth pattern and phenotype. EBV immortalized cells express a set of 11 viral genes to accommodate B cell activation and proliferation, whereas EBV-positive Burkitt lymphoma cells highly express the c-myc oncogene that is activated through translocation into 1 of the immunoglobulin loci and EBNA1 as the only viral protein. We have developed a primary human B cell line conditionally immortalized by Epstein-Barr virus in which the viral gene program responsible for the induction of proliferation can be switched on and off by the addition or withdrawal of estrogen (cell line EREB2-5). Starting from this cell line we have generated 2 daughter cell lines that proliferate in a c-myc dependent fashion, 1 with a highly active exogenous c-myc gene (cell line A1) and 1 with a regulatable c-myc gene that can be switched on by withdrawal and switched off by addition of tetracycline (cell line P493-6). The comparison of the 3 cell lines has allowed us to dissect the contribution of c-myc and EBV genes to the regulation of the growth pattern and expression of cell surface molecules. We show that MYC and EBNA2 (and their respective target genes) have opposing effects on the expression of several surface markers involved in B cell activation. We show that MYC contributes to the phenotype of Burkitt lymphoma cells by upregulating CD10 and CD38 and downregulating activation markers. The phenotype of the cells is determined on one hand by the absence of the viral gene products EBNA2 and LMP1 that mediate the phenotype of activated lymphoblasts and to a lesser extent by an active contribution of the c-myc gene.
Subject(s)
Antigens, CD , B-Lymphocytes/metabolism , Herpesvirus 4, Human/genetics , Proto-Oncogene Proteins c-myc/genetics , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Antigens, Differentiation/metabolism , Blotting, Western , Cell Division , Cell Line , Cell Separation , Dose-Response Relationship, Drug , Down-Regulation , Epstein-Barr Virus Nuclear Antigens/genetics , Flow Cytometry , Humans , Lymphocyte Activation , Membrane Glycoproteins , NAD+ Nucleosidase/metabolism , Neprilysin/metabolism , Phenotype , Recombinant Fusion Proteins/metabolism , Tetracycline/pharmacology , Time Factors , Transfection , Tumor Cells, Cultured , Up-Regulation , Viral Matrix Proteins/genetics , Viral ProteinsABSTRACT
Reactive astrocytes occurring in response to neurodegeneration are thought to play an important role in neuronal regeneration by upregulating the expression of extracellular matrix (ECM) components as well as the ECM degrading metalloproteinases (MMPs). We examined the mRNA levels and cellular distribution of membrane type matrix metalloproteinase 1 (MT1-MMP) and tissue inhibitors 1-4 of MMPs (TIMPs) in brain stem and spinal cord of wobbler (WR) mutant mice affected by progressive neurodegeneration and astrogliosis. MT1-MMP, TIMP-1 and TIMP-3 mRNA levels were elevated, whereas TIMP-2 and TIMP-4 expression was not affected. MT1-MMP was expressed in reactive astrocytes of WR. In primary astrocyte cultures, MT1-MMP mRNA was upregulated by exogeneous tumor necrosis factor alpha. Increased plasma membrane and secreted MMP activities were found in primary WR astrocytes.
Subject(s)
Astrocytes/enzymology , Central Nervous System/enzymology , Metalloendopeptidases/biosynthesis , Neurodegenerative Diseases/enzymology , Animals , Astrocytes/immunology , Astrocytes/pathology , Cell Line , Cells, Cultured , Central Nervous System/pathology , Enzyme Induction/genetics , Enzyme Induction/immunology , Gene Expression Regulation/immunology , Matrix Metalloproteinase 14 , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/genetics , Mice , Mice, Inbred C57BL , Mice, Neurologic Mutants , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/pathology , RNA, Messenger/biosynthesis , Recombinant Proteins/pharmacology , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Tissue Inhibitor of Metalloproteinase-1/genetics , Tissue Inhibitor of Metalloproteinase-2/biosynthesis , Tissue Inhibitor of Metalloproteinase-2/genetics , Tissue Inhibitor of Metalloproteinase-3/biosynthesis , Tissue Inhibitor of Metalloproteinase-3/genetics , Tissue Inhibitor of Metalloproteinases/biosynthesis , Tissue Inhibitor of Metalloproteinases/genetics , Tumor Necrosis Factor-alpha/pharmacology , Up-Regulation/genetics , Up-Regulation/immunology , Tissue Inhibitor of Metalloproteinase-4ABSTRACT
The product of the proto-oncogene c-myc (myc) is a potent activator of cell proliferation. In Burkitt lymphoma (BL), a human B-cell tumor, myc is consistently found to be transcriptionally activated by chromosomal translocation. The mechanisms by which myc promotes cell cycle progression in B-cells is not known. As a model for myc activation in BL cells, we have established a human EBV-EBNA1 positive B-cell line, P493-6, in which myc is expressed under the control of a tetracycline regulated promoter. If the expression of myc is switched off, P493-6 cells arrest in G0/G1 in the presence of serum. Re-expression of myc activates the cell cycle without inducing apoptosis. myc triggers the expression of cyclin D2, cyclin E and Cdk4, followed by the activation of cyclin E-associated kinase and hyper-phosphorylation of Rb. The transcription factor E2F-1 is expressed in proliferating and arrested cells at constant levels. The Cdk inhibitors p16, p21, p27 and p57 are expressed at low or not detectable levels in proliferating cells and are not induced after repression of myc. Ectopic expression of p16 inhibits cell cycle progression. These data suggest that myc triggers proliferation of P493-6 cells by promoting the expression of a set of cell cycle activators but not by inactivating cell cycle inhibitors.
Subject(s)
Burkitt Lymphoma/physiopathology , Cell Cycle Proteins/physiology , Cell Cycle/physiology , Neoplasm Proteins/physiology , Proto-Oncogene Proteins c-myc/physiology , Burkitt Lymphoma/metabolism , Cell Cycle Proteins/antagonists & inhibitors , Cyclin-Dependent Kinase Inhibitor p16/physiology , Humans , Neoplasm Proteins/antagonists & inhibitors , Nuclear Proteins/metabolism , Phosphorylation , Protein Synthesis Inhibitors/pharmacology , Proto-Oncogene Mas , Proto-Oncogene Proteins c-myc/antagonists & inhibitors , Retinoblastoma Protein/metabolism , Retinoblastoma-Like Protein p107 , Tetracycline/pharmacology , Tumor Cells, CulturedABSTRACT
CD8-positive cytotoxic T cells (CTL) recognize antigenic peptides in combination with major histocompatibility complex (MHC) class I molecules on the surface of syngeneic antigen presenting cells (APC). In the present paper we show that cells from tumor antigen-specific CTL clones present their cognate antigenic peptide to other CTL from the same clone. Inter-CTL peptide presentation resulted in activation of the cells of one CTL clone to MHC-unrestricted lysis of bystander cells. In contrast to the behaviour of this clone, another CTL clone did not lyse bystander cells after incubation with the cognate peptide, but was activated to self-destruction. The human herpes virus Epstein-Barr virus is involved in the pathogenesis of a broad spectrum of human neoplasias. Using freshly established non-clonal T cells with specificity for a peptide derived from an Epstein-Barr virus encoded antigen we found again lysis of MHC mismatched bystander cells as a consequence of inter-CTL peptide presentation, indicating that bystander lysis following antigen self-presentation is not a phenomenon restricted to long-term in vitro cultured T cell clones. The potential implications for immunosurveillance against cancer and for tumor escape mechanisms are discussed.
Subject(s)
Antigen Presentation/immunology , T-Lymphocytes, Cytotoxic/immunology , Cell Line, Transformed , Cytotoxicity, Immunologic , HLA-A2 Antigen/immunology , Humans , Tumor Cells, CulturedABSTRACT
The c-Myc protein (Myc) is a transcription factor, and deregulated expression of the c-myc gene (myc) is frequently found in tumours. In Burkitt's lymphoma (BL), myc is transcriptionally activated by chromosomal translocation. We have used a B-cell line called P493-6 that carries a conditional myc allele to elucidate the role of Myc in the proliferation of BL cells. Regulation of proliferation involves the coordination of cell growth (accumulation of cell mass) and cell division [1] [2] [3]. Here, we show that division of P493-6 cells was strictly dependent on the expression of the conditional myc allele and the presence of foetal calf serum (FCS). More importantly, cell growth was regulated by Myc without FCS: Myc alone induced an increase in cell size and positively regulated protein synthesis. An increase in protein synthesis is thought to be one of the causes of cell mass increase. Furthermore, Myc stimulated metabolic activities, as indicated by the acidification of culture medium and the activation of mitochondrial enzymes. Our results confirm the model that Myc is involved in the regulation of cell growth [4] and provide, for the first time, direct evidence that Myc induces cell growth, that is, an increase in cell size, uncoupled from cell division.
Subject(s)
Cell Division/physiology , Proto-Oncogene Proteins c-myc/physiology , Cell Line, Transformed , Cell Size/physiology , Culture Media/metabolism , HumansSubject(s)
B-Lymphocytes/virology , Burkitt Lymphoma/etiology , Genes, myc , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/pathogenicity , Cell Transformation, Neoplastic , Epstein-Barr Virus Nuclear Antigens/genetics , Epstein-Barr Virus Nuclear Antigens/metabolism , Genes, Viral , Humans , Immunoglobulin mu-Chains/metabolism , Tumor Cells, Cultured , Viral Matrix Proteins/geneticsABSTRACT
Cytotoxic T cells (CTL) not only act as effector cells, but can also serve as antigen-presenting cells (APC) for other CTL due to their expression of major histocompatibility complex (MHC) class I molecules. In the present study we show that independently derived CTL lines (CTLL) with specificity for an L(d)-presented nonapeptide corresponding to amino acids 168-176 of the immediate-early 1 (IE1) protein of murine cytomegalovirus not only lyse syngeneic but also allogeneic target cells, if the peptide is present during the cytolytic assay. Whereas a short peptide pulse is sufficient to render syngeneic cells susceptible to lysis, continued presence of soluble peptide is mandatory for the lysis of allogeneic target cells. This indicates a difference in the mechanisms involved. Syngeneic BALB/c B cell blasts (K(d)D(d)L(d)) and mutant BALB/c-H-2dm2 B cell blasts lacking the restricting Ld molecules (K(d)D(d)0) were lysed to a similar extent in the absence of the IE1 nonapeptide, provided that the IE1-specific CTL had been pre-incubated with the peptide before the cytolytic assay. Since the mutant cells cannot present the IE1 peptide, their lysis indicates an MHC-unrestricted, peptide-independent mode of recognition by the CTLL. In addition, proliferation of the CTLL takes place after incubation with the cognate peptide, even in the absence of professional APC. These data indicate inter-CTL antigen self-presentation, resulting in activation of the lytic machinery leading to peptide-independent bystander lysis of allogeneic as well as syngeneic target cells.
Subject(s)
Antigen Presentation , Histocompatibility Antigens Class I/immunology , Immediate-Early Proteins/immunology , Major Histocompatibility Complex/immunology , T-Lymphocytes, Cytotoxic/immunology , Viral Proteins , Animals , Antigens, Viral/immunology , Cells, Cultured , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Tumor Cells, CulturedABSTRACT
In enterobacteria-induced reactive arthritis (ReA), different T cell subsets play a role in the induction and maintenance of the synovitic process. Synovial fluid-derived alphabeta CD4, alphabeta CD8, and gammadelta T lymphocyte clones (TLC) that recognize Yersinia or Salmonella antigens on professional antigen-presenting cells (APC) have been characterized, and T cells themselves can function as nonprofessional APC. T cells were infected with the facultatively intracellular, arthritogenic enterobacterium Yersinia enterocolitica O:3. A CD8 TLC isolated from a patient with Yersinia-induced ReA recognized and efficiently lysed autologous and allogeneic Yersinia-infected T cells. Infected cytotoxic T lymphocytes (CTL) had a reduced lytic capacity against syngeneic and allogeneic infected target cells, suggesting that the infection of CTL by bacteria may represent a mechanism of immune escape. In ReA, antigen presentation by T cells may modify the antibacterial immune response and may also contribute to network control mechanisms of T cell-mediated cytotoxicity.
Subject(s)
Antigen-Presenting Cells/microbiology , Antigens, Bacterial/immunology , Arthritis, Reactive/immunology , Salmonella typhimurium/immunology , T-Lymphocytes, Cytotoxic/microbiology , T-Lymphocytes/microbiology , Yersinia Infections/immunology , Yersinia enterocolitica/immunology , Animals , Antigen-Presenting Cells/immunology , B-Lymphocytes/immunology , B-Lymphocytes/microbiology , Clone Cells , Humans , Immunity, Cellular , L Cells , Mice , Microscopy, Electron , Prohibitins , T-Lymphocyte Subsets/immunology , T-Lymphocytes/immunology , T-Lymphocytes/ultrastructure , T-Lymphocytes, Cytotoxic/immunology , Tumor Cells, CulturedABSTRACT
Cytotoxic T lymphocytes (CTLs) recognize peptide fragments derived from endogenous proteins, processed internally, and presented at the cell surface by major histocompatibility complex (MHC) class I molecules. The use of specific CTL for cancer therapy is limited because of their dependence on effective processing and presentation of appropriate antigenic peptides. Structural alterations, like point mutation or somatic loss, or dysregulation of key elements in the processing or presentation pathway, may allow cells to escape the immune surveillance. Indeed, the expression of MHC class I antigens on the surface of virus- and oncogene-transformed cells is low and correlates with tumorigenicity. Transformation of murine fibroblasts with the ras oncogene results in the suppression of cell surface expression of all H-2 loci as determined by FACScan analysis using a panel of monoclonal antibodies. We then examined whether the oncogene-mediated suppression of MHC class I surface expression was associated with reduced recognition of transformants by CD8+ T lymphocytes. Murine T lymphoma cells were stably transfected by the Ha-ras oncogene. The transfectants expressed distinct levels of the Ha-ras specific protein p21. Again, immunofluorescence analysis demonstrated an inverse correlation between oncogene and MHC class I surface expression in RMAras transformants. Allogeneic H-2Kb-restricted cytotoxic T lymphocytes were able to efficiently lyse the parental T lymphoma cells. In contrast, the CTL-mediated lysis of ras transformants was significantly downregulated compared with untransfected RMA cells. The efficiency of CTL-mediated lysis of RMAras cells was directly associated with reduced MHC class I membrane and high p21ras protein expression. Thus, the oncogene-mediated downregulation of MHC class I surface expression resulted in a reduced CTL response. Attempts are in progress to revert the defects in MHC class I surface expression of oncogenic transformants by introducing the different elements of the antigen presentation pathway. Such studies will not only provide improved understanding of the mechanisms of tumor escape, but also will suggest strategies to repair cellular defects in cancer patients having impaired expression of MHC class I antigens.